ISB Partners with Procter & Gamble on Skin Conditions Research

Feb 04, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute for Systems Biology said today that it will collaborate with consumer health products giant Procter & Gamble on research to characterize the systems biology of various skin conditions.

The collaboration will leverage ISB's expertise in regulatory network inference and modeling and P&G's expertise in skin biology and dermatology to characterize and develop models of the global molecular changes that occur in skin under different conditions. The partners believe the research will benefit both of their interests: ISB's in skin diseases, such as skin cancer, and P&G's in skin care.

The collaboration will include work on the systems biology of respiratory rhinovirus infection.

Further details of the alliance were not disclosed.

Filed under

research alliance

ISB

systems biology

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.